Our partnering work
Partnering with the Japan Pharmaceutical Manufacturers Association (JPMA)
JPG works closely with the JPMA – we seek to bring the Japanese voice closer to UK decision-making and do this in a number of ways: including through responses to consultations, attitudinal research and bilateral meetings.
Since 2024 we have been delighted to collaborate with the Japan Society in hosting annual events for a JPMA delegation led by its Vice President, Dr Sunao Manabe, former CEO and now Executive Chairman of Daiichi Sankyo.
Future Opportunities in the UK Life Sciences Ecosystem – Key Determinants of Progress
To mark its annual visit, JPG collaborates with the JPMA on an official ‘Communique’ that is presented to Ministers. These documents set out the Japanese global pharmaceutical industry perspectives on the UK life sciences ecosystem, and current Government policy to support future inward investment and economic growth.
The competitiveness of the UK as a location for global investment by the Japanese biopharmaceutical industry October 2024 & 2025 - surveys
Our goal with the survey was to provide the Government with useful insights that can contribute to the development of its Life Sciences policy. It covers prospects for future Japanese investment, key factors influencing investment and recommendations.Originally conducted in 2024 we repeated the exercise in 2025 and produced a summary report for each.